Publications by authors named "Antoine Ferry"

Claim this Profile
D
Drug repurposing: From the discovery of a useful pharmacological effect to making the treatment available to the patient.
Dominique Deplanque, Christine Fetro, Antoine Ferry, Philippe Lechat, Terence Beghyn

Therapie· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Not Available].
Dominique Deplanque, Christine Fetro, Antoine Ferry, Philippe Lechat, Terence Beghyn

Therapie· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[The RARE 2017 meeting for companies developing products for rare patients].
Antoine Ferry

Med Sci (Paris)· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Conclusions of the RARE 2017 meeting].
Nathalie Triclin-Conseil, Ségolène Aymé, Antoine Ferry

Med Sci (Paris)· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Aganirsen antisense oligonucleotide eye drops inhibit keratitis-induced corneal neovascularization and reduce need for transplantation: the I-CAN study.
Claus Cursiefen, Eric Viaud, Felix Bock, Bernard Geudelin, Antoine Ferry

Ophthalmology· September 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The antiangiogenic insulin receptor substrate-1 antisense oligonucleotide aganirsen impairs AU-rich mRNA stability by reducing 14-3-3β-tristetraprolin protein complex, reducing inflammation and psoriatic lesion size in patients.
Sylvie Colin, Bernadette Darné, Amin Kadi, Antoine Ferry, Maryline Favier

J Pharmacol Exp Ther· April 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Conference 1. An economic observatory for orphan drugs: myth or reality?].
Christophe Duguet, Antoine Ferry

Med Sci (Paris)· April 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Presenting a research project on rare diseases to industrial companies].
Antoine Ferry

Presse Med· May 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Medicoeconomic data on rare disease drugs: a move towards more transparency?].
Annick Schwebig, Christophe Duguet, Antoine Ferry, Claude Bougé, Jean-Yves Fagon

Presse Med· May 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antiangiogenic activity of aganirsen in nonhuman primate and rodent models of retinal neovascular disease after topical administration.
Frank Cloutier, Matthew Lawrence, Robin Goody, Stéphanie Lamoureux, Salman Al-Mahmood, Antoine Ferry

Invest Ophthalmol Vis Sci· March 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis